Opens profile photo
Follow
Click to Follow czbiohub
Chan Zuckerberg Biohub
@czbiohub
Our mission is to make fundamental discoveries and to develop new technologies that will help to cure, prevent, or manage all disease by the end of the century.
San Francisco, CAczbiohub.orgJoined July 2017

Chan Zuckerberg Biohub’s Tweets

We're proud to have supported this important new work by looking at genetic mutations in long-lived corals and how those mutations may actually result in better adaptation to changing climates.
Quote Tweet
Some corals live to be hundreds and, even thousands of years old. They were born with genes that were successful back in their parent’s generation, so how can these old corals still be successful now? Especially in a changing climate? stanford.io/3JaCayP
Image
6
Fascinating research with implications for human evolution led by Katie Pollard, Biohub Investigator and director of the of Data Science and Biotechnology:
Quote Tweet
Many changes to the genomes of early humans had opposing effects from each other, possibly because of a delicate balance between improved cognition and psychiatric disease risk @seawhalen @NadavAhituv @Lab_Pollen @UCSF_Epibiostat @UCSF @czbiohub @NIMHgov bit.ly/3kgR1NX
1
3
If the test is negative for all 3, the sample will undergo metagenomic sequencing to see what else may be surging. Joe DeRisi said of the method: “These are all things that lead to making better diagnostics and intervention — but you don’t get that by not asking the question.”
2
Show this thread
Have respiratory symptoms and negative for covid, flu, & RSV? Metagenomic sequencing may tell you what it is. Biohub is partnering with & to test for the 3 viruses in an "all-in-one" test and determine if anything is surging in the Bay.
Quote Tweet
You’re coughing, you’re feverish, but it’s not Covid-19. Recent hospital data suggest it could be RSV or the flu… or it could be something else entirely. The 24th and Capp Street site will figure it out for you. All you gotta do is swab. Via @AnnikaHom missionlocal.org/2023/01/test-f
1
5
Show this thread
Kim says: "We now have a formulation that is very inexpensive to manufacture that we think is suitable for use in everybody—including infants, which is a big deal because there is not a good option for young children and infants." 10/n
Image
1
3
Show this thread
Kim's spike design was informed by a Biohub + study done with #Covid patient sera that showed a region of spike elicits very strong antibody activity but not neutralization. After lopping off that section, Kim's vaccine worked much better. bit.ly/3jfnROG 9/n
6
Show this thread
Kim says the goal is for the shot to be "cheaper than the syringes containing it." He made a cell line that produces 1000s of doses per liter of cell culture. As a protein-based vax, it’s simpler to make than mRNA vaccines, which need lipid nanoparticles to protect the mRNA. 8/n
3
3
Show this thread
This vaccine could be ideally suited for pediatric vaccination, a huge unmet need globally. The vaccine's sole adjuvant is alum, which has been in use for >90 yrs, incl. in many of the vaccines given to infants, and has an excellent FDA safety profile. 7/n
1
4
Show this thread
What's more, the vaccine was kept at temps up to 37C (99F) for 14 days with no impact on its potency. Having to maintain a cold chain has been one of the obstacles to wider mRNA vaccine distribution in low-income countries. 6/n
Image
1
3
Show this thread
Non-human primates that received a booster more than one year after initial immunization still showed a strong immune response, suggesting that boosters of the vaccine could be required just once a year. 5/n
Image
1
4
Show this thread
Kim & team designed a vaccine to offer affordable worldwide access. DCFHP, as he calls it, is a ferritin-based nanoparticle that is studded with 8 SARS-CoV-2 spike protein trimers, perfectly structured to create a strong antibody response. 3/n
Image
3
4
Show this thread
Apply by 12/31 for the CZ Biohub Summer Internship Program! The 10-week program allows students to conduct exciting research & work closely with scientists and mentors – preparing them to enter #STEMCareers and fostering connections between diverse groups.
1
Thrilled for the Knight Initiative’s support to enable our new research!
Quote Tweet
Congratulations to the recipients of our inaugural 2022 Brain Resilience Innovation awards! These exciting projects will pursue bold, untried approaches to advance the science of #brainhealth. Read more: neuroscience.stanford.edu/initiatives-an
Quote about Brain Resilience Innovation Awards
“These innovative proposals will pursue transformative ideas outside the mainstream that will advance our mission to extend the healthy lifespan of the human brain,” says Tony Wyss-Coray, Director of the Knight Initiative for Brain Resilience
5
Preeclampsia is one of top 3 causes of maternal death globally. Now, a team from has created a prediction model to detect preeclampsia early in pregnancy – which could enable better monitoring and development of more effective treatments.
We think biology and physics are meant to be together! Learn more at our upcoming Physics of Life symposium. Registration open to all and abstracts accepted from early-career researchers until Jan. 9. Details on our blog:
14